James Momtazee (Menlo Park) joined KKR in 1996 and is Head of the Health Care industry team within KKR’s Americas Private Equity platform. His role would include oversight of Health Care Private Equity transactions as well as the Health Care Strategic Growth (HCSG) and Health Care Royalty & Income (HCRI) strategies. He is on the Investment Committee and Portfolio Management Committee for Americas’ Private Equity and HCSG and is on the Investment Committee for HCRI. He currently serves on the board of directors of Ajax Health, BridgeBio, Envision Healthcare, Global Medical Response, Heartland Dental, Pharmerica and PRA Health Sciences. He was also involved in the previous investments in HCA and Jazz Pharmaceuticals. Prior to joining KKR, Mr. Momtazee was with Donaldson, Lufkin & Jenrette where he worked on a broad range of corporate finance, mergers and acquisitions, and merchant banking transactions. He holds an A.B. with distinction, Phi Beta Kappa, from Stanford University and an M.B.A., Arjay Miller Scholar, from Stanford University Graduate School of Business.